Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Tanaka

Showing results (101-110 of 279) with videos related to

Pageof 28
Sort By:
Clinical and Experimental Nephrology|June 29, 2020
Estimated plasma osmolarity and risk of end-stage kidney disease in patients with IgA nephropathyShigeru Tanaka, Toshiaki Nakano, Masanori Tokumoto, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 26, 2025
Association between the urinary sodium-to-potassium ratio and apparent treatment-resistant hypertension in Japanese patients with non-dialysis dependent chronic kidney disease: the Fukuoka Kidney disease Registry studyYuta Matsukuma, Shigeru Tanaka, Masaru Nakayama, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 28, 2018
Association of B-Type Natriuretic Peptide Level With Residual Kidney Function in Incident Peritoneal Dialysis PatientsYasuhiro Kawai, Shigeru Tanaka, Hisako Yoshida, et al.
Chest|February 16, 2006
Cavitating invasive pulmonary aspergillosis visualized and diagnosed by ultrathin bronchoscopyMasahide Oki, Hideo Saka, Chieko Sako, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2014
Interleukin-21-producing c-Maf-expressing CD4+ T cells induce effector CD8+ T cells and enhance autoimmune inflammation in scurfy miceTaro Iwamoto, Akira Suto, Shigeru Tanaka, et al.
International Cancer Conference Journal|March 31, 2021
Positive outcome of first-line therapy for a SMARCA4-deficient thoracic sarcomatoid tumorShigeru Tanaka, Shuhei Hayashi, Yoshitaka Isobe, et al.
Clinical and Experimental Nephrology|February 4, 2023
Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD)Mai Seki, Toshiaki Nakano, Shigeru Tanaka, et al.
Journal of Atherosclerosis and Thrombosis|January 24, 2024
Relationships of Weight Change from 20 Years of Age with the Risks of All-Cause and Cardiovascular Mortality in Patients with Chronic Kidney DiseaseKazuhiro Okamura, Shigeru Tanaka, Hiromasa Kitamura, et al.
Journal of Pharmacological Sciences|February 18, 2022
Potential role of inducible GPR3 expression under stimulated T cell conditionsHiroko Shiraki, Shigeru Tanaka, Yun Guo, et al.
Stroke|June 12, 2004
Infiltrating macrophages as in vivo targets for intravenous gene delivery in cerebral infarctionShigeru Tanaka, Kazuo Kitagawa, Shiro Sugiura, et al.
Pageof 28

Showing results (101-110 of 279) with videos related to

Sort By:
Pageof 28
Clinical and Experimental Nephrology|June 29, 2020
Estimated plasma osmolarity and risk of end-stage kidney disease in patients with IgA nephropathyShigeru Tanaka, Toshiaki Nakano, Masanori Tokumoto, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 26, 2025
Association between the urinary sodium-to-potassium ratio and apparent treatment-resistant hypertension in Japanese patients with non-dialysis dependent chronic kidney disease: the Fukuoka Kidney disease Registry studyYuta Matsukuma, Shigeru Tanaka, Masaru Nakayama, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 28, 2018
Association of B-Type Natriuretic Peptide Level With Residual Kidney Function in Incident Peritoneal Dialysis PatientsYasuhiro Kawai, Shigeru Tanaka, Hisako Yoshida, et al.
Chest|February 16, 2006
Cavitating invasive pulmonary aspergillosis visualized and diagnosed by ultrathin bronchoscopyMasahide Oki, Hideo Saka, Chieko Sako, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2014
Interleukin-21-producing c-Maf-expressing CD4+ T cells induce effector CD8+ T cells and enhance autoimmune inflammation in scurfy miceTaro Iwamoto, Akira Suto, Shigeru Tanaka, et al.
International Cancer Conference Journal|March 31, 2021
Positive outcome of first-line therapy for a SMARCA4-deficient thoracic sarcomatoid tumorShigeru Tanaka, Shuhei Hayashi, Yoshitaka Isobe, et al.
Clinical and Experimental Nephrology|February 4, 2023
Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD)Mai Seki, Toshiaki Nakano, Shigeru Tanaka, et al.
Journal of Atherosclerosis and Thrombosis|January 24, 2024
Relationships of Weight Change from 20 Years of Age with the Risks of All-Cause and Cardiovascular Mortality in Patients with Chronic Kidney DiseaseKazuhiro Okamura, Shigeru Tanaka, Hiromasa Kitamura, et al.
Journal of Pharmacological Sciences|February 18, 2022
Potential role of inducible GPR3 expression under stimulated T cell conditionsHiroko Shiraki, Shigeru Tanaka, Yun Guo, et al.
Stroke|June 12, 2004
Infiltrating macrophages as in vivo targets for intravenous gene delivery in cerebral infarctionShigeru Tanaka, Kazuo Kitagawa, Shiro Sugiura, et al.
Pageof 28